Rick Bright, former director of the Biomedical Advanced Research and Development Authority, testifies Thursday before the House Energy and Commerce Subcommittee on Health.

Rick Bright, former director of the Biomedical Advanced Research and Development Authority, testifies Thursday before the House Energy and Commerce Subcommittee on Health. Shawn Thew/Pool via AP

‘I Was Met With Indifference’: Whistleblower Testifies on HHS Leaders' Response to His Early Coronavirus Concerns

Former vaccine agency director removed from position after speaking out implores Trump administration to let federal scientists "speak truthfully without fear of retribution."

A prominent federal whistleblower told lawmakers on Thursday his early concerns about the novel coronavirus went ignored by top Trump administration officials, adding that the advice of career scientists has been routinely sidelined throughout the government’s response. 

Rick Bright ultimately lost his job as director of the Biomedical Advanced Research and Development Authority within the Health and Human Services Department due to his outspokenness over his concerns, the career federal scientist said. Bright has filed a whistleblower complaint with the Office of Special Counsel after his removal and reassignment to another position in the National Institutes of Health. OSC has issued a preliminary ruling in Bright’s favor, according to his attorneys. 

The United States remains significantly unprepared for a mass manufacturing and deployment of a treatment or vaccine for COVID-19, Bright told the House Energy and Commerce Committee’s panel on health, suggesting the government needs an interagency, comprehensive plan to to ramp up testing, boost supplies and deliver potential treatments. Bright repeatedly said that HHS Secretary Alex Azar, Assistant Secretary for Preparedness and Response Robert Kaldec and other department officials ignored his warnings in mid-January. He implored the Trump administration to listen to scientific experts as it develops response plans going forward. 

“The truth must be based on scientific evidence and not filtered for political reasons,” Bright said. “We must know and appreciate what we are up against. We have the world’s greatest scientists—they must be permitted to lead. Let them speak truthfully without fear of retribution.”

Bright highlighted several issues he raised that he said went ignored. In January, he asked Azar and Kaldec for more money, virus samples and staffing. BARDA was not immediately provided with the samples, which Bright said led to further delays in developing countermeasures and, ultimately, an end to stay-home orders. He also said he sounded the alarm on shortages of personal protective equipment in the national stockpile, though top officials pushed aside the warning. 

“It clearly was not an issue he wanted to discuss on that day,” Bright said of one of his conversations with Kaldec. “We were rebuffed.” 

The former director recalled receiving dozens of notices in January from private sector business owners raising concerns about disruptions to the supply chain and the challenges that could present for securing the requisite equipment if the virus continued to spread. He said he would “never forget” an email he received from a manufacturer of N95 respirators who wrote, “We’re in deep shit. The world is, and we need to act.” He forwarded each of those messages up the chain of command, but they were not taken seriously, he said. 

“On each of those I was met with indifference,” Bright said, recalling that officials responded by “saying either they were too busy, they didn’t have a plan, they didn’t know who was responsible for procuring those, in some cases they had a sick child and would get back to it later in the week. A number of excuses and never any action.” 

He added that as he continued to raise the issue of mask shortages, HHS officials told him the Centers for Disease Control and Prevention could simply revise its guidelines to tell fewer Americans to wear masks and thereby save the reserves for frontline health care workers. 

“I cannot believe you would sit there and say that with a straight face,” Bright recalled responding. “That is absurd.”

Bright said he continued his push for procuring more PPE and other necessary supplies, including syringes and swabs, into February and March. Eventually, he said, he was cut out of "key, high-level meetings to combat COVID-19" because, he was told, his comments were “causing a commotion.” Bright said he reached out to White House adviser Peter Navarro directly after his own supervisors ignored his concerns, and praised Navarro for taking his concerns seriously and helping deliver results in some cases. That led, however, to Bright facing increased "hostility and marginalization" at HHS. He said he ultimately was pushed out of his position after he sounded the alarm about what he viewed as the administration’s overzealous pursuit of hydroxychloroquine as a treatment for COVID-19.

Bright acknowledged there was a need to move swiftly in trials but cautioned research must be conducted carefully and in a clinical setting under a physician’s supervision. He spoke out when he learned of an effort to push the drug on a widespread basis in hard-hit communities like New York and New Jersey. Under significant pressure, Bright said his team agreed to issue an “expanded access protocol” for the drug so its use would at least have some guardrails in place guaranteeing close physician supervision. His resistance in that case, he said, was the “straw that broke the camel’s back” leading to his removal. 

Democrats on the panel praised Bright for his bravery in coming forward. Rep. Anna Eshoo, D-Calif., who chairs the subcommittee, said Bright filed “one of the most specific and troubling whistleblower complaints I’ve ever seen.” 

“He was not only ignored, he was fired for being right,” Eshoo said. “We can’t have a system where the government fires those who get it right.”

Rep. John Sarbanes, D-Md., said the Trump administration was following a “dangerous impulse” to dismiss science for political considerations. 

“Here we are at a moment when our country needs the kind of expertise and science-based guidance that you and others like you can offer us,” Sarbanes said. “These voices are too often being sidelined.” 

Most Republicans, meanwhile, questioned Bright’s motives and timeline. They followed President Trump’s example, who tweeted at the outset of the hearing that Bright should be removed from government entirely. 

“I don’t know the so-called whistleblower Rick Bright,” Trump said, “never met him or even heard of him, but to me he is a disgruntled employee, not liked or respected by people I spoke to and who, with his attitude, should no longer be working for our government!”

Rep. Markwayne Mullin, R-Okla., questioned why Bright had to take sick leave, and subsequently annual leave, for symptoms related to stress from his dismissal while still maintaining the capacity to file a whistleblower complaint and testify to Congress. 

“I just want to make sure you’re not doing something to deceive the American people,” Mullin said. 

Bright cautioned the 12- to 18-month timeline for developing a COVID-19 vaccine is likely overly optimistic. He said that while the government could have done better and taken more critical steps earlier in the process, the country can still mitigate the pandemic’s impact going forward by listening to the advice of career scientists. 

“We can devise a comprehensive strategy, we can devise a plan,” he said. “Time is running out because the virus is still spreading everywhere.” 

On Thursday, House Democrats announced they will add a measure to protect science and scientists at federal agencies to a $3 trillion bill to help the country respond to and recover from the pandemic.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.